Healthcare - Biotechnology - NASDAQ - US
$ 2.01
-10.7 %
$ 74 M
Market Cap
-1.63
P/E
Price Target
Average
397.51%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
32.19%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
PDS Biotechnology Corporation
Wall Street analysts predict an average 1-year price target for PDSB of $10 , with forecasts ranging from a low of $9 to a high of $11 .
PDSB Lowest Price Target
Wall Street Target
9 USD
347.76%
PDSB Average Price Target
Wall Street Target
10 USD
397.51%
PDSB Highest Price Target
Wall Street Target
11 USD
447.26%
REVENUE FORECAST
Revenue Forecast Chart PDSB
EBIT FORECAST
EBIT Forecast Chart PDSB
NET INCOME FORECAST
Net Income Chart PDSB